The LATAM Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The LATAM Ledger.

Press releases published on October 30, 2026

Oct. 30, 2026

NeOnc’s Ambitious Brain Cancer Plans are Setting the Stage

Indeterminate GlobeNewswire

Oct. 30, 2026

Atsena Therapeutics Reports New Preclinical Data Demonstrating Robust MYO7A Expression and Favorable Safety for ATSN-301, a Laterally Spreading Dual AAV Vector-based Gene Therapy for Usher Syndrome Type 1B

Indeterminate GlobeNewswire

Oct. 30, 2026

Enstar Strengthens Executive Leadership Team

Indeterminate GlobeNewswire

Oct. 30, 2026

Stallion Uranium Announces Strategic Technical Partnership with Axiom Exploration Group and Corporate Update

Indeterminate GlobeNewswire

Oct. 30, 2026

Banco Santander-Chile Reports Strong Third Quarter 2026 Results, Driven by Continued Customer Growth, Higher Profitability and Stable Capital Levels

Indeterminate GlobeNewswire

Oct. 30, 2026

Acumen Pharmaceuticals Announces Topline Results from Phase 2 ALTITUDE-AD Clinical Trial of Sabirnetug (ACU193) for the Treatment of Early Alzheimer’s Disease; Trial Did Not Meet Primary Endpoint

Indeterminate GlobeNewswire

Oct. 30, 2026

Agios Announces New PDUFA Goal Date of February 1, 2027, for Mitapivat Sickle Cell Disease sNDA; Company Is Launch-Ready and in Labeling Discussions with FDA

Indeterminate GlobeNewswire

Oct. 30, 2026

Banco Itaú Chile Announces Third Quarter 2026 Management Commentary

Indeterminate GlobeNewswire

Oct. 30, 2026

Goliath Resources Closes $9,800,000 Non-Brokered

Indeterminate GlobeNewswire

Oct. 30, 2026

Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter 2026

Indeterminate GlobeNewswire

Oct. 30, 2026

Leads Biolabs Doses First Patient with Systemic Lupus Erythematosus in Phase I Part B Trial of LBL-047, a First-in-Class BDCA2/TACI Bifunctional Fusion Protein

Indeterminate GlobeNewswire